Trial Profile
Clinical Trials Insight: 700024091
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 25 Jun 2007
Price :
$35
*
At a glance
- Drugs Irinotecan/floxuridine (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 25 Jun 2007 New trial record.